<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0009104.ref035">
 <label>35</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fresno Vara</surname>
   <given-names>JA</given-names>
  </name>, 
  <name>
   <surname>Casado</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>de Castro</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Cejas</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Belda-Iniesta</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>González-Barón</surname>
   <given-names>M</given-names>
  </name>. 
  <article-title>PI3K/Akt signalling pathway and cancer</article-title>. 
  <source>Cancer Treat Rev</source>
  <year>2004</year>;
  <volume>30</volume>: 
  <fpage>193</fpage>–
  <lpage>204</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ctrv.2003.07.007</pub-id>
  <?supplied-pmid 15023437?>
  <pub-id pub-id-type="pmid">15023437</pub-id>
 </mixed-citation>
</ref>
